EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diphenyl diselenide protects against diabetic kidney disease through modulating gut microbiota dysbiosis in streptozotocin-induced diabetic rats

Xing Wang, Dongmei Long, Xingcan Peng, Jiaxuan Li, Maoting Zhou, Yu Wang, Xianghong Hu

Frontiers in Pharmacology · 03.12.2024 · 15

DOI: 10.3389/fphar.2024.1506398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.12.2024. Verfasst von Xing Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, North Sichuan Medical College, Nanchong, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diphenyl diselenide (DPDS) ameliorates nephropathy in streptozotocin (STZ)-induced type 1 diabetic rats by inhibiting oxidative stress and inflammatory reactions. However, it has not been clarified whether DPDS alleviates type 1 diabetic kidney disease (DKD) is related to the inhibition of extracellular matrix (ECM) production and the regulation of intestinal flora disorder.

Methods

The present study investigated the effects of DPDS on ECM generation in the kidney and intestinal microflora composition in feces. The rats were orally administered DPDS or metformin for eight weeks. Various indices were measured to assess the severity of renal injury. After euthanizing the rats, oxidative stress markers in serum and kidney were assessed using biochemical methods, and the expressions of ECM-related proteins in kidney were analyzed using Western blot. Additionally, 16S rRNA high-throughput sequencing was used to evaluate the diversity and composition of the intestinal flora in feces.

Results

The results showed DPDS and metformin improved the DKD in STZ rats, as evidenced by decreased blood glucose, BUN, urine volume, urine microalbumin, urinary β2 microglobulin, and improvement of renal pathological morphology. Furthermore, DPDS intervention markedly reduced the protein expression of α-SMA, COI Ⅳ, FN, and vimentin in the kidneys. Besides, DPDS not only improved dyslipidemia in STZ diabetic rats, but also enhanced the activities of antioxidant enzymes, decreased the level of MDA in serum and kidney, and regulated the expression of proteins related to the Nrf2/Keap1 signaling pathway in the kidney. Moreover, we found that DPDS could selectively improve the relative abundance of probiotics as well as the diversity of flora, thus ameliorating the intestinal microbial composition of the STZ rats, significantly regulating the intestinal microbial homeostasis.

Discussion

Overall, DPDS inhibited ECM production and improved renal pathological changes, which may be related to reducing oxidative stress damage in the kidney and improving intestinal flora imbalance, providing data support for the further development and application of DPDS in DKD.

Schlagwörter

Stichwörter der Autor:innen

Nrf2/Keap1 signalingdiabetic nephropathydiphenyl diselenideextracellular matrixgut microbiotaoxidative stress

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmacy, North Sichuan Medical College, Nanchong, China.
  • Nanchong Key Laboratory of Disease Prevention, Control and Detection in Livestock and Poultry, Nanchong Vocational and Technical College, Nanchong, China.

Zitieren

APA

Wang, X., Long, D., Peng, X., Li, J., Zhou, M., Wang, Y., & Hu, X. (2024). Diphenyl diselenide protects against diabetic kidney disease through modulating gut microbiota dysbiosis in streptozotocin-induced diabetic rats. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1506398

Vancouver

Wang X, Long D, Peng X, Li J, Zhou M, Wang Y, et al. Diphenyl diselenide protects against diabetic kidney disease through modulating gut microbiota dysbiosis in streptozotocin-induced diabetic rats. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1506398

BibTeX
@article{Wang2024,
  author = {Wang, Xing and Long, Dongmei and Peng, Xingcan and Li, Jiaxuan and Zhou, Maoting and Wang, Yu and Hu, Xianghong},
  title = {Diphenyl diselenide protects against diabetic kidney disease through modulating gut microbiota dysbiosis in streptozotocin-induced diabetic rats},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1506398}
}
Kostenlos starten →